The subsidies allow insurers to hold down overall premiums under the Affordable Care Act.
A federal judge has found that the Trump administration can stop making cost-sharing reductions (CSRs) while weighing a state program to keep the insurer subsidies intact.
Judge Vince Chhabria denied a preliminary injunction to 18 states and the District of Columbia, which sought to keep the subsidies under the Affordable Care Act (ACA) intact. The CSRs help insurers hold down overall premiums while meeting the ACA requirements to keep down costs for Americans with the lowest income.
While acknowledging the CSRs had helped achieve a core goal of the ACA—dramatically lowering rates of the uninsured—Chhabria wrote that the states failed to meet the bar needed for a preliminary injunction, and suggests that the administration likely has the stronger argument. House Republicans had sued, and won a lower court ruling that Congress had not, in fact, appropriated funds for the CSRs.
Chhabria wrote, in fact, that “the emergency relief sought by the states would be counterproductive.”
Bipartisan legislation being considered in the Senate, sponsored by Senators Lamar Alexander, R-Tennessee, and Patty Murray, D-Washington, would restore the CSRs through 2019 and grant states additionally flexibility to craft waivers. Yesterday, the Congressional Budget Office found that the legislation would reduce the deficit by $3.8 billion while keeping coverage rates stable.
Report Reveals Mounting Burdens of Drug Shortages on US Health System
June 27th 2025Vizient's 2024 survey reveals a sharp rise in drug shortages across US health care, with pediatric care hit especially hard and labor costs soaring—but the true impact may go far beyond limited medication access, threatening to disrupt the very foundations of how health systems operate.
Read More
Blister Packs May Help Solve Medication Adherence Challenges and Lower Health Care Costs
June 10th 2025Julia Lucaci, PharmD, MS, of Becton, Dickinson and Company, discusses the benefits of blister packaging for chronic medications, advocating for payer incentives to boost medication adherence and improve health outcomes.
Listen